“According to the research report, the global irritable bowel syndrome (IBS) treatment market was valued at USD 3.69 billion in 2023 and is expected to reach USD 7.60 billion by 2032, to grow at a CAGR of 8.4% during the forecast period.”
Industry Overview
The careful analysis and meticulous efforts of expert analysts, skilled researchers, and professional forecasters have...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian